NM_152618.3(BBS12):c.2T>C (p.Met1Thr) AND Bardet-Biedl syndrome
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- May 1, 2022
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV002531306.2
Allele description [Variation Report for NM_152618.3(BBS12):c.2T>C (p.Met1Thr)]
NM_152618.3(BBS12):c.2T>C (p.Met1Thr)
Condition(s)
Assertion and evidence details
Last Updated: Sep 29, 2024